| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $526.5M | +22.5% |
| R&D Expense | $85.8M | -3.4% |
| SG&A Expense | $124.5M | -3.7% |
| Pre-tax Income | -$203.9M | +11.3% |
| Income Tax | -$1.7M | -123.9% |
| Net Income | -$202.2M | +14.6% |
| EPS (Basic) | -$2.85 | +16.2% |
| EPS (Diluted) | -$2.85 | +16.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $376.0M | +42.2% |
| Short-term Investments | $27.5M | -40.0% |
| Total Assets | $1.85B | +13.2% |
| Total Liabilities | $1.26B | +35.8% |
| Stockholders' Equity | $593.4M | -16.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.4M | +90.4% |
| Capital Expenditures | $9.4M | +2.2% |
| Investing Cash Flow | $40.6M | -54.2% |
| Financing Cash Flow | $87.7M | +469.5% |
| Free Cash Flow | -$20.8M | +83.8% |